Home >> Life Sciences >> Healthcare

Global Ascites Market Research Report - Forecast to 2023

Published: Dec-2018 | Format: PDF | Market Research Future | Number of pages: 122 | Code: MRS - 226858

 Ascites is an abnormal accumulation fluid in the abdominal cavity. Liver cirrhosis is the most common case of ascites. Its presence is a sign of significant portal hypertension. Other less common factors that may contribute to ascites development are heart failure, kidney failure, cancers, and infection in pancreas. Malignant ascites has a characteristic role in the progression of ovarian cancer. Malignancy-related ascites have also been observed in malignancies of breast, lung, pancreas, gastric, and liver. Ascites can be detected by physical examination at a volume greater than 1.5 ascites. For smaller amount of fluid ultrasound, and CT scan are preferred.

Notably, rising prevalence of cirrhosis, improvement in reimbursement policies, and increasing occurrence of cancer are promoting the growth of ascites market globally. Ascites is a major complication of cirrhosis and is also an important landmark of chronic liver disease in the natural history. The rising alcohol consumption directly leads to the rising hospitalized cases and mortality due to alcoholic liver cirrhosis. Rising prevalence of cirrhosis and its related complications directly promotes the growth of ascites market.

However, complications associated with ascites treatment may hamper the market growth in coming future.
The global ascites market is expected to reach USD 3710.4 million by 2023 from USD 2806.1 million in 2016. This market is expected to grow at a stable CAGR of 4.0% during the forecast period d 2017-2023.

On the basis of type, the global ascites market is classified into transudative ascites, and exudate ascites. In 2016, exudate ascites segment commanded the largest market share of global ascites market by type segment. 

On the basis of diagnosis, the global ascites ultrasound, CT scan, laparoscopy, angiography, and others. Ultrasound segment commanded the largest market share of 25.9% in 2016, and this segment is also expected to grow at a fastest CAGR of 4.4% during the forecast period 2017 to 2023.

On the basis of treatment, the global ascites market is segmented into surgeries, and others. Surgeries segment is further segmented into peritoneovenous shunting, liver transplantation, transjugular intrahepatic portosystemic shunt (TIPS), others. The surgeries market is projected to reach USD 2119.2 million by the end of 2023 at the CAGR of 4.3% during 2017 to 2023.

On the basis of end user, the global ascites market is segmented into hospitals & clinics, ambulatory surgical center, and diagnostic centers. The hospitals & clinics market is projected to reach USD 1,133.2 million by the end of 2023 at the CAGR of 4.4% during 2017 to 2023.

On the basis of regions, the market is segmented into Americas, Europe, Asia-Pacific and the Middle East & Africa. The Americas hold the largest share of the global ascites market and is expected to reach USD 1,292.2 million by 2023. Asia Pacific is the fastest growing market, which is expected to grow at a CAGR of 4.5% over the 2017-2023 

Key Players

Some of key the players in the ascites market are Sequana Medical, BioVie, PharmaCyte Biotech Inc., Fresenius SE & Co. KGaA, BD, GI Supply, Medtronic plc, and others.

Study objectives

  • To provide comprehensive analysis of ascites industry and its sub-segments in the global market, thereby providing a detailed structure of the industry.

  • To provide detailed insights into the factors driving and restraining the growth of global ascites market.

  • To estimate the market size of global ascites from 2014 to 2023. Wherein, 2014 & 2015 would be the historic period, 2016 shall be the base year, and 2017 – 2023 will be forecast period for the study.

  • To analyze global ascites market, on the basis of four main geographies namely, Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To compare the products with respect to the various players in the market

  • To provide country wise market value analysis for various segments of ascites market

  • To understand the demand-supply scenario and provide gap analysis of the industry

  • To analyze and provide upcoming technologies and trends in ascites market

  • To provide strategic profiling of key companies (manufacturers and distributors) present across the globe, and comprehensively analyze their competitiveness/competitive landscape in this market.

Target Audience

  • Ascites manufacturers

  • Ascites Suppliers

  • Ascites Distributors

  • Medical Device companies

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities

Key Findings

  • Americas accounted for the largest market share in the global ascites market, It is estimated to reach  USD 1,292.2 million by 2023

  • Exudate ascites type of ascites is expected to command the largest market share of 55.8%

  • The ultrasound segment is expected to command the largest market share of 9% over the review period and it is also expected to grow at the fastest CAGR of 4.4% during the forecast period 2017-2023

The reports also covers regional analysis

• Americas
o North America
? US
? Canada
o South America

• Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

Table of Contents:

1  Report Prologue
2  Market Introduction
2.1  Research Objective
2.2  Assumptions & Limitations
2.2.1  Assumptions
2.2.2  Limitations
2.3  Market Structure
3  Research Methodology
3.1  Introduction
3.1.1  Primary Research Methodology
3.1.2  Secondary Research Methodology
3.1.3  Market Share Analysis
3.1.4  Trade Analysis
3.1.5  Market Pricing Approach
4  Market Dynamics
4.1  Introduction
4.2  Drivers
4.2.1  Rising Prevalence of Cirrhosis (Impact Weightage: 35%)
4.2.2  Improvement in Reimbursement Policies (Impact Weightage: 30%)
4.2.3  Increasing Occurrence of Cancer (Impact Weightage: 35%)
4.3  Restraints
4.3.1  Complications associated with the ascites treatment
4.4  Opportunity
4.4.1  Development of Innovative Treatment Options
4.5  Macroeconomic Indicators
5  Market Factor Analysis
5.1  Porter’s Five Forces Model
5.1.1  Bargaining Power of Suppliers
5.1.2  Bargaining Power of Buyers
5.1.3  Threat of New Entrants
5.1.4  Threat of Substitutes
5.1.5  Intensity of Rivalry
5.2  Value Chain Analysis: Global Ascites Market
5.2.1  R&D and Designing
5.2.2  Manufacturing
5.2.3  Distribution & Sales
5.2.4  Post-sales Monitoring
5.3  Demand & Supply: Gap Analysis
5.4  Pricing Analysis
6  Global Ascites Market by Types
6.1  Introduction
6.2  Transudative Ascites
6.3  Exudate Ascites
7  Global Ascites Market by Diagnosis
7.1  Introduction
7.2  Ultrasound
7.3  CT scan
7.4  Laparoscopy
7.5  Angiography
8  Global Ascites Market by Treatment
8.1  Introduction
8.2  Surgeries
9  Global Ascites Market by End Users
9.1  Introduction
9.2  Hospitals & Clinics
9.3  Ambulatory Surgical Center
9.4  Diagnostic Centres
10  Global Ascites Market by Regions
10.1  Introduction
10.2  Americas
10.2.1  North America  US  Canada
10.2.2  South America  Brazil  Colombia  Mexico  Rest of South America
10.3  Europe
10.3.1  Western Europe  Germany  France  UK  Italy  Spain  Rest of Western Europe
10.3.2  Eastern Europe
10.4  Asia Pacific
10.4.1  China
10.4.2  Japan
10.4.3  India
10.4.4  Australia
10.4.5  Republic of Korea
10.4.6  Rest of Asia Pacific
10.5  Middle East & Africa
10.5.1  Middle East  UAE  Saudi Arabia  Oman  Kuwait  Qatar  Rest of Middle East
10.5.2  Africa
11  Competitive Analysis
11.1  Sequana Medical
11.1.1  Company Overview
11.1.2  Financials
11.1.3  Products
11.1.4  Strategy
11.1.5  Key Developments
11.2  BioVie
11.2.1  Company Overview
11.2.2  Financials
11.2.3  Products
11.2.4  Strategy
11.2.5  Key Developments
11.3  PharmaCyte Biotech Inc.
11.3.1  Company Overview
11.3.2  Financials
11.3.3  Products
11.3.4  Strategy
11.3.5  Key Developments
11.4  Fresenius SE & Co. KGaA
11.4.1  Company Overview
11.4.2  Financials
11.4.3  Products
11.4.4  Strategy
11.4.5  Key Developments
11.5  BD
11.5.1  Company Overview
11.5.2  Financials
11.5.3  Products
11.5.4  Strategy
11.5.5  Key Developments
11.6  GI Supply
11.6.1  Company Overview
11.6.2  Financials
11.6.3  Products
11.6.4  Strategy
11.6.5  Key Developments
11.7  Medtronic
11.7.1  Company Overview
11.7.2  Financials
11.7.3  Products
11.7.4  Strategy
11.7.5  Key Developments
12  Conclusion
12.1  Key Findings
12.1.1  From CEO’s View Point
13  Appendix
13.1  Discussion Blue Print


Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

Single User | $(USD)4450 View Pricing